Roche Holding | Nettoeinkommen



Net Income Veränderung Datum
AbbVie USD 938M 348M 2025-06
Alcon AG USD 350M 66M 2025-03
Almirall EUR 26.58M 4.98M 2025-06
Amgen USD 1.43B 298M 2025-06
AstraZeneca USD 2.45B 466M 2025-06
Bayer EUR -199000000 1.5B 2025-06
Biogen USD 634.8M 394.3M 2025-06
Bristol-Myers Squibb USD 1.31B 1.15B 2025-06
Eli Lilly USD 5.66B 2.9B 2025-06
Fresenius EUR 330M 101M 2025-06
Fresenius Medical Care EUR 225M 74M 2025-06
Galapagos EUR -105748000 47.66M 2025-06
Genmab DKK 195M 3.65B 2025-03
Gilead Sciences USD 1.96B 645M 2025-06
GlaxoSmithKline GBP 1.44B 181M 2025-06
GRIFOLS EUR 117.06M 57.34M 2025-06
Hikma Pharmaceutical USD 133M 93M 2024-12
Lonza CHF 307M 22M 2024-12
Merck EUR 652M 83M 2025-06
Merck USD 4.43B 652M 2025-06
Novartis USD 4.02B 418M 2025-06
Orion EUR 82.5M 21.3M 2025-06
Pfizer USD 2.91B 58M 2025-06
Philips EUR 240M 165M 2025-06
Recordati EUR 91.08M 33.96M 2025-06
Regeneron Pharmaceuticals USD 1.39B 582.9M 2025-06
Roche Holding CHF 1.01B 2.12B 2024-12
Sanofi EUR 3.94B 2.07B 2025-06
UCB EUR 857M 649M 2024-12


Roche Holding Nettoeinkommen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.